HGH Pilot Trial Enhances Speech Clarity in Males with Chronic Broca’s Aphasia
Reading Time: < 1 minute Introduction Aphasia, a debilitating language impairment often resulting from cerebrovascular accidents (CVAs), affects approximately 1 million Americans annually, with males comprising over 60% of cases due to higher stroke incidence in this demographic (Virani et al., 2021). In the United States, where cardiovascular risk factors like hypertension and obesity disproportionately impact men aged 45-75, post-stroke aphasia manifests as reduced speech clarity, fluency deficits, and articulatory imprecision, severely compromising quality of life and socioeconomic productivity. Traditional rehabilitative strategies, including speech-language pathology (SLP) and pharmacotherapeutics like piracetam, yield modest gains, prompting exploration of neurotrophic agents. Human growth hormone (HGH), a 191-amino-acid polypeptide...


